TRANSPLANTATION PROCEEDINGS, cilt.54, sa.3, ss.658-662, 2022 (SCI-Expanded)
Purpose. In this study, we aimed to investigate the effect of long-term administration of alendronate to treat bone loss in renal transplant patients.